View all newsletters
NIH found new target proteins for anti-malaria drugs and Netherlands Cancer Institute (NCI) discovered a new way to fight cancer. Pharmaceutical-technology.com wraps up the key headlines…
GlaxoSmithKline (GSK) has submitted a biologics licence application to the US Food and Drug Administration (FDA) for approval of…
Human Metabolome Technologies (HMT) has been contracted by the National Institute on Aging (NIA) to study brain metabolomic profiles…
ByResearchers at the University of Liverpool, UK, are exploring the use of nanotechnology to improve administration and availability of…
ByElsevier has selected four start-up companies for its new incubator project, The Hive, for biotech and pharmaceutical start-up firms.
ByMilo Biotechnology has secured Orphan Drug designation for its AAV1-FS344 from the Federal Drug Administration’s (FDA) Office of Orphan…
ByPharmaceutical company Eisai has launched Uritos tablets (imidafenacin) to treat overactive bladder (OAB), in Thailand.
Israeli-based Teva Pharmaceutical Industries has completed the acquisition of Allergan’s generic pharmaceuticals distributor Anda, as part of a previously…
AbbVie's investigational, pan-genotypic regimen of glecaprevir (ABT-493) / pibrentasvir (ABT-530) (G/P) has received breakthrough therapy designation from the US…
Thank you for subscribing to Pharmaceutical Technology